Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

L20. Memory T-cells in vasculitis.

Lamprecht P.

Presse Med. 2013 Apr;42(4 Pt 2):560-3. doi: 10.1016/j.lpm.2013.01.019. Epub 2013 Feb 28. Review. No abstract available.

PMID:
23453997
2.

L27. Antibodies versus phenotypes: a clinician's view.

Jayne D.

Presse Med. 2013 Apr;42(4 Pt 2):579-82. doi: 10.1016/j.lpm.2013.01.027. Epub 2013 Mar 9. Review. No abstract available.

PMID:
23490640
3.

[T-cells in ANCA-associated vasculitis].

Lamprecht P, Kabelitz D.

Z Rheumatol. 2011 Oct;70(8):698-700. doi: 10.1007/s00393-011-0780-z. Review. German.

PMID:
21979321
4.

L29. Relevance of anti-LAMP-2 in vasculitis: why the controversy.

Kain R.

Presse Med. 2013 Apr;42(4 Pt 2):584-8. doi: 10.1016/j.lpm.2013.01.029. Epub 2013 Feb 28. Review. No abstract available.

PMID:
23453500
5.

L3. Are mononuclear cells predominant actors of endothelial damage in vasculitis?

Abdulahad WH, De Souza AW, Kallenberg CG.

Presse Med. 2013 Apr;42(4 Pt 2):499-503. doi: 10.1016/j.lpm.2013.02.305. Epub 2013 Mar 7. Review. No abstract available.

PMID:
23477715
6.

Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.

Kallenberg CG, Stegeman CA, Abdulahad WH, Heeringa P.

Am J Kidney Dis. 2013 Dec;62(6):1176-87. doi: 10.1053/j.ajkd.2013.05.009. Epub 2013 Jun 28. Review.

PMID:
23810690
7.

L31. A GWAS in ANCA-associated vasculitis: will genetics help re-define clinical classification?

Lyons PA, Smith KG.

Presse Med. 2013 Apr;42(4 Pt 2):589-91. doi: 10.1016/j.lpm.2013.02.303. Epub 2013 Mar 11. Review. No abstract available.

PMID:
23490642
8.

[Pathophysiology of eosinophilic granulomatosis with polyangitis (Churg-Strauss)].

Chaigne B, Dion J, Guillevin L, Mouthon L, Terrier B.

Rev Med Interne. 2016 May;37(5):337-42. doi: 10.1016/j.revmed.2015.10.339. Epub 2016 Mar 9. Review. French.

PMID:
26971201
9.

L32. ANCA vasculitis over the world. What do we learn from country differences?

Watts RA, Scott DG.

Presse Med. 2013 Apr;42(4 Pt 2):591-3. doi: 10.1016/j.lpm.2013.01.032. Epub 2013 Mar 6. Review. No abstract available.

PMID:
23481365
10.

L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?

Holle JU.

Presse Med. 2013 Apr;42(4 Pt 2):616-9. doi: 10.1016/j.lpm.2013.01.041. Epub 2013 Mar 6. No abstract available.

PMID:
23481358
11.

Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?

Millet A, Pederzoli-Ribeil M, Guillevin L, Witko-Sarsat V, Mouthon L.

Postgrad Med J. 2014 May;90(1063):290-6. doi: 10.1136/postgradmedj-2013-203255rep. Review.

PMID:
24737903
12.

Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan.

Kobayashi S, Fujimoto S, Takahashi K, Suzuki K.

Kidney Blood Press Res. 2010;33(6):442-55. doi: 10.1159/000320383. Epub 2010 Nov 10. Review.

13.

L34. Neutrophils in ANCA-associated vasculitis: still under investigation.

Witko-Sarsat V.

Presse Med. 2013 Apr;42(4 Pt 2):595-7. doi: 10.1016/j.lpm.2013.01.034. Epub 2013 Mar 6. Review. No abstract available.

PMID:
23481359
14.

Venous thromboembolic events in systemic vasculitis.

Novikov P, Makarov E, Moiseev S, Meshkov A, Strizhakov L.

Ann Rheum Dis. 2015 Mar;74(3):e27. doi: 10.1136/annrheumdis-2014-206849. Epub 2014 Nov 7. No abstract available.

PMID:
25381230
15.

B-cell-targeted therapy in systemic vasculitis.

Lally L, Spiera R.

Curr Opin Rheumatol. 2016 Jan;28(1):15-20. doi: 10.1097/BOR.0000000000000235. Review.

PMID:
26599379
16.

Rituximab and B-cell return in ANCA-associated vasculitis.

Wilde B, Witzke O, Cohen Tervaert JW.

Am J Kidney Dis. 2014 Jun;63(6):1066. doi: 10.1053/j.ajkd.2013.11.029. No abstract available.

PMID:
24856618
17.

Key advances in the clinical approach to ANCA-associated vasculitis.

Kallenberg CG.

Nat Rev Rheumatol. 2014 Aug;10(8):484-93. doi: 10.1038/nrrheum.2014.104. Epub 2014 Jul 1. Review.

PMID:
24980139
18.

In reply to 'rituximab and B-cell return in ANCA-associated vasculitis'.

Kallenberg CG, Stegeman CA, Abdulahad WH, Heeringa P.

Am J Kidney Dis. 2014 Jun;63(6):1066-7. doi: 10.1053/j.ajkd.2014.02.028. No abstract available.

PMID:
24856617
19.

Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis.

Willeke P, Schl├╝ter B, Sauerland C, Becker H, Reuter S, Jacobi A, Schotte H.

PLoS One. 2015 Sep 4;10(9):e0137196. doi: 10.1371/journal.pone.0137196. eCollection 2015.

20.

The spectrum of pulmonary vasculitis.

DeRemee RA.

Monaldi Arch Chest Dis. 1996 Feb;51(1):35-8. Review.

PMID:
8901319

Supplemental Content

Support Center